ICSI: a technique too far?1
- 17 March 2003
- journal article
- review article
- Published by Wiley in International Journal of Andrology
- Vol. 26 (2) , 63-69
- https://doi.org/10.1046/j.1365-2605.2003.00380.x
Abstract
Even now 10 years after its introduction, there is still debate on the possible adverse effects of intracytoplasmic sperm injection (ICSI). ICSI has raised a lot of concerns because of the mechanical perforation of the oocyte, the possible transmission of foreign genetic material, the use of immature or senescent germ cells and the association between genetic disorders and some forms of male infertility. To date, the data available indicate that ICSI is a safe procedure provided this treatment is performed in clinics with the highest standards of expertise and with a continuous follow-up programme for the offspring. It is becoming increasingly apparent that it is not ICSI itself, but the background risks of the ICSI patients that represent the major risk factor with regard to congenital malformations. More sex-chromosome abnormalities have been reported in ICSI offspring. Again, the risk of aneuploidy in ICSI progeny reflects the higher aneuploidy rate in the sperm of ICSI fathers. Whether ICSI will eventually perpetuate male infertility is far from clear, because at present the inheritance pattern of idiopathic male infertility is unknown. All ICSI candidates should nevertheless be thoroughly screened and counselled. As long as follow-up studies have a limited power to detect small increases in malformations and as long as no information is available on long-term and next-generation cohorts, ICSI must be used with caution and only when no alternative evidence-based therapy is available. All ICSI candidates should be rigorously screened and thoroughly informed of the limitations of current screening methods and our limited knowledge of the genetic background to male infertility. They should be told that there might be a slight increase in congenital malformation rate after ICSI, but that this increase is probably the result of their own 'background risk'. Well-informed patients are in the best position to judge whether the concerns outweigh the benefits of ICSI.Keywords
This publication has 63 references indexed in Scilit:
- Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999)Human Reproduction, 2002
- Frequency of hyper-, hypohaploidy and diploidy in ejaculate, epididymal and testicular germ cells of infertile patientsHuman Reproduction, 2000
- Seven years of intracytoplasmic sperm injection and follow-up of 1987 subsequent childrenHuman Reproduction, 1999
- Outcome of pregnancies after intracytoplasmic sperm injection and the effect of sperm origin and quality on this outcomeFertility and Sterility, 1998
- Mental development of 201ICSI children at 2 years of ageThe Lancet, 1998
- Medical and developmental outcome at 1 year for children conceived by intracytoplasmic sperm injectionThe Lancet, 1998
- Commentary: major defects are overestimatedBMJ, 1997
- Comparison of gonosomal aneuploidy in spermatozoa of normal fertile men and those with severe male factor detected by in-situ hybridizationMolecular Human Reproduction, 1997
- Cytogenetic analysis of uncleaved oocytes after intracytoplasmic sperm injectionJournal of Assisted Reproduction and Genetics, 1995
- Intragenic Deletion of theKALIG-1Gene in Kallmann's SyndromeNew England Journal of Medicine, 1992